Medline Inc. (MDLN)

NASDAQ: MDLN · USD

$32.4

-0.02 (-0.1%)· Recorded snapshot

Market cap	42.5B
Revenue (ttm)	29.9B
Net income (ttm)	701M
EPS (ttm)	$0.80
Shares out	1.3B
P/E (trailing)	40.7x
P/E (forward)	22.0x
Volume	6,092,025

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 29.9B
Net income (ttm): 701M
EPS (ttm): $0.80
P/E (trailing): 40.7x
P/E (forward): 22.0x
Market cap: 42.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E22

P25 n/aP50 n/aP75 n/a

Trailing P/E40.7

P25 n/aP50 n/aP75 n/a

ROE4.9

P25 n/aP50 n/aP75 n/a

ROIC4.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All MDLN indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002046386
Company name	Medline Inc.
Country	United States
Country code	US
CUSIP number	58507V107
Earnings date	2026-11-04
Earnings time	bmo
Employees	45,000
Employees change	2,000
Employees growth	4.65%
Enterprise value	$52.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-27
First seen	2026-05-09
Fiscal year end	December
Founded	1966
Industry	Medical Instruments & Supplies
IPO date	2025-12-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US58507V1070
Last 10-K release date	2026-02-25
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$42.5B
Market cap category	Large-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$32.36
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	MDLN
U.S. state	Illinois
Website	https://www.medline.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	2.46%
EV/Earnings	74.87x
EV/EBIT	35.13x
EV/EBITDA	20.84x
EV/FCF	33.95x
EV/Sales	1.75x
FCF / EV yield	2.95%
FCF yield	3.63%
Forward EV/Sales	1.62x
Forward P/E	22.04x
Forward P/S	1.32x
Graham number	15.37024
Graham upside	-52.5%
Industry forward P/E	22.69x
Industry P/E	75.18x
P/(FCF - SBC) ratio	29.3x
P/(OCF - SBC) ratio	22.42x
P/B ratio	2.45x
P/E ratio	40.67x
P/FCF ratio	27.52x
P/OCF ratio	21.36x
P/S ratio	1.42x
PEG ratio	2.64x
Price/EBITDA ratio	16.9x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	4.99%
EBITDA margin	8.41%
Effective tax rate	18.29%
FCF margin	5.16%
Gross margin	25.09%
Operating margin	4.99%
Pretax margin	3.6%
Profit margin	2.31%
Profit per employee	$15,578
Profitable quarters	6
Profitable years	1
Revenue per employee	$665,311
ROA	2.46%
ROCE	4.08%
ROE	4.94%
ROIC	4.16%
SBC / revenue	0.31%
Tax / revenue	0.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	998.36%
EPS growth (Q)	261.98%
EPS growth (QoQ)	-57.48%
EPS growth years	0
FCF growth	41.97%
FCF growth (Q)	1,018.52%
FCF growth (QoQ)	91.14%
Gross profit growth	2.4%
Gross profit growth (Q)	-1.15%
Net income growth	-45.35%
Net income growth (Q)	-81.98%
Net income growth (QoQ)	-57.25%
Net income growth years	0
OCF growth	30.37%
OCF growth (Q)	262.94%
OCF growth (QoQ)	73.54%
Operating income growth	-33.24%
Operating income growth (Q)	-89.98%
Revenue growth	12.12%
Revenue growth (Q)	11.6%
Revenue growth (QoQ)	4.53%
Revenue growth quarters	4
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-446M
Depreciation and amortization	$1B
EBIT	$1.5B
EBITDA	$2.5B
EPS	$0.80
FCF per share	$1.18
Financing cash flow	$564M
Free cash flow	$1.5B
Free cash flow minus SBC	$1.5B
Gross profit	$7.5B
Income taxes	$197M
Investing cash flow	$-796M
Net borrowing	$-4.1B
Net cash flow	$1.7B
Net income	$701M
Operating cash flow minus SBC	$1.9B
Operating income	$1.5B
Revenue	$29.9B
Stock-based compensation	$94M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.21
Book value per share	$13.19
Debt / EBITDA	4.76
Debt / equity	0.66
Debt / FCF	8.18
Goodwill	$8.1B
Interest coverage	1.91
Long-term assets	$27.6B
Long-term liabilities	$17.6B
Net cash (debt)	$-9.9B
Net cash / market cap	-23.36%
Net debt / EBITDA	3.95
Net debt / equity	0.52
Net debt / FCF	6.43
Piotroski F-Score	6
Property, plant and equipment	$4.7B
Shareholders' equity	$19.1B
Tangible book value	$-10B
Tangible book value per share	$-11.45
Total assets	$39.4B
Total cash	$2.7B
Total debt	$12.6B
Total liabilities	$20.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.79
Current assets	$11.7B
Current liabilities	$2.7B
Current ratio	4.33
Inventory turnover	4.81
Net working capital	$6.4B
Quick ratio	2.45
Working capital	$9B
Working capital turnover	3.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	94.99%
Dividend yield	0%
Shareholder yield	94.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$38.09
1D price change	-0.06%
1M price change	-7.49%
1M total return	-7.49%
1W price change	-9.48%
1W total return	-9.48%
20-day SMA	$35.12
200-day SMA	$39.76
3M price change	-19.14%
3M total return	-19.14%
50-day SMA	$34.55
50-day SMA vs 200-day SMA	50under200
52-week high	$50.88
52-week high date	2026-02-25
52-week low	$31.49
52-week low date	2026-09-18
6M price change	-29.03%
6M total return	-29.03%
All-time high	$50.88
All-time high date	2026-02-25
All-time low	$31.49
All-time low date	2026-09-18
Average true range (ATR)	$1.12
Average volume	8.2M
Beta (1Y)	0.92
Change from 52-week high	-36.39%
Change from 52-week low	2.76%
Change from all-time high	-36.91%
Change from all-time low	1.94%
Change from open	0.28%
Day's gap	-0.34%
Dollar volume	$197.1M
High price	$32.70
Low price	$32.07
Monthly RSI	0
Open price	$32.27
Position in 52-week range	46.03%
Premarket change	-0.65%
Premarket close	$32.38
Premarket price	$32.17
Premarket volume	18.9K
Previous close	$32.38
Price vs 150-day SMA	-15.71%
Price vs 20-day SMA	-8.6%
Price vs 200-day SMA	-19.26%
Price vs 50-day SMA	-7.09%
Relative volume	0.74
Return from IPO open	-7.54%
Return from IPO price	11.59%
RSI	30.8
Sharpe ratio	-0.52
Sortino ratio	-0.57
Volume	6.1M
Weekly RSI	40
YTD price change	-23.57%
YTD total return	-23.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	369.5M
Float percentage	28.11%
Shares change (QoQ)	4.37%
Shares change (YoY)	-94.99%
Shares held by insiders	1.11%
Shares held by institutions	61.29%
Shares outstanding	1.3B
Short % of float	14.26%
Short % of shares	4.01%
Short ratio	6.1 days

Deeper analysis on MDLN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this MDLN report

Is a complete MDLN research report available?

No complete published report is available for Medline Inc. (MDLN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Medline Inc. (MDLN)

Price

Financial snapshot

Fair-value bridge

Latest news · MDLN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MDLN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MDLN

Frequently asked questions